vs
Side-by-side financial comparison of Fat Brands, Inc (FAT) and IDEAYA Biosciences, Inc. (IDYA). Click either name above to swap in a different company.
IDEAYA Biosciences, Inc. is the larger business by last-quarter revenue ($207.8M vs $140.0M, roughly 1.5× Fat Brands, Inc). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs -41.6%, a 99.0% gap on every dollar of revenue. IDEAYA Biosciences, Inc. produced more free cash flow last quarter ($142.2M vs $-16.9M).
FAT Brands Inc. is an American multi-brand restaurant and sports bar franchise operator headquartered in Beverly Hills, California.
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
FAT vs IDYA — Head-to-Head
Income Statement — Q3 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $140.0M | $207.8M |
| Net Profit | $-58.2M | $119.2M |
| Gross Margin | — | — |
| Operating Margin | -12.4% | 52.2% |
| Net Margin | -41.6% | 57.4% |
| Revenue YoY | -2.3% | — |
| Net Profit YoY | -30.1% | 330.1% |
| EPS (diluted) | $-3.39 | $1.33 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $140.0M | $207.8M | ||
| Q2 25 | $146.8M | — | ||
| Q1 25 | $142.0M | — | ||
| Q4 24 | $145.3M | — | ||
| Q3 24 | $143.4M | $0 | ||
| Q2 24 | $152.0M | $0 | ||
| Q1 24 | $152.0M | $0 | ||
| Q4 23 | $158.6M | — |
| Q3 25 | $-58.2M | $119.2M | ||
| Q2 25 | $-54.2M | — | ||
| Q1 25 | $-46.0M | — | ||
| Q4 24 | $-67.4M | — | ||
| Q3 24 | $-44.8M | $-51.8M | ||
| Q2 24 | $-39.4M | $-52.8M | ||
| Q1 24 | $-38.3M | $-39.6M | ||
| Q4 23 | $-26.2M | — |
| Q3 25 | -12.4% | 52.2% | ||
| Q2 25 | -10.6% | — | ||
| Q1 25 | -6.0% | — | ||
| Q4 24 | -27.1% | — | ||
| Q3 24 | -6.2% | — | ||
| Q2 24 | -1.8% | — | ||
| Q1 24 | -0.9% | — | ||
| Q4 23 | -2.0% | — |
| Q3 25 | -41.6% | 57.4% | ||
| Q2 25 | -36.9% | — | ||
| Q1 25 | -32.4% | — | ||
| Q4 24 | -46.4% | — | ||
| Q3 24 | -31.2% | — | ||
| Q2 24 | -25.9% | — | ||
| Q1 24 | -25.2% | — | ||
| Q4 23 | -16.5% | — |
| Q3 25 | $-3.39 | $1.33 | ||
| Q2 25 | $-3.17 | — | ||
| Q1 25 | $-2.73 | — | ||
| Q4 24 | $-4.06 | — | ||
| Q3 24 | $-2.74 | $-0.60 | ||
| Q2 24 | $-2.43 | $-0.68 | ||
| Q1 24 | $-2.37 | $-0.53 | ||
| Q4 23 | $-1.68 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $786.9M |
| Total DebtLower is stronger | $1.3B | — |
| Stockholders' EquityBook value | $-585.8M | $1.1B |
| Total Assets | $1.2B | $1.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $786.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $920.0M | ||
| Q2 24 | — | $701.7M | ||
| Q1 24 | — | $698.8M | ||
| Q4 23 | — | — |
| Q3 25 | $1.3B | — | ||
| Q2 25 | $1.3B | — | ||
| Q1 25 | $1.3B | — | ||
| Q4 24 | $1.3B | — | ||
| Q3 24 | $1.2B | — | ||
| Q2 24 | $1.2B | — | ||
| Q1 24 | $1.2B | — | ||
| Q4 23 | $1.2B | — |
| Q3 25 | $-585.8M | $1.1B | ||
| Q2 25 | $-536.5M | — | ||
| Q1 25 | $-493.9M | — | ||
| Q4 24 | $-455.7M | — | ||
| Q3 24 | $-386.1M | $1.2B | ||
| Q2 24 | $-338.6M | $931.7M | ||
| Q1 24 | $-296.8M | $935.3M | ||
| Q4 23 | $-255.9M | — |
| Q3 25 | $1.2B | $1.2B | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $1.3B | — | ||
| Q4 24 | $1.3B | — | ||
| Q3 24 | $1.3B | $1.2B | ||
| Q2 24 | $1.4B | $973.7M | ||
| Q1 24 | $1.4B | $961.5M | ||
| Q4 23 | $1.4B | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-14.5M | $142.2M |
| Free Cash FlowOCF − Capex | $-16.9M | $142.2M |
| FCF MarginFCF / Revenue | -12.1% | 68.4% |
| Capex IntensityCapex / Revenue | 1.7% | 0.0% |
| Cash ConversionOCF / Net Profit | — | 1.19× |
| TTM Free Cash FlowTrailing 4 quarters | $-75.0M | $13.5M |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $-14.5M | $142.2M | ||
| Q2 25 | $-26.9M | — | ||
| Q1 25 | $-13.2M | — | ||
| Q4 24 | $-10.4M | — | ||
| Q3 24 | $-3.2M | $-49.2M | ||
| Q2 24 | $-14.2M | $-32.9M | ||
| Q1 24 | $-28.4M | $-43.8M | ||
| Q4 23 | $-12.6M | — |
| Q3 25 | $-16.9M | $142.2M | ||
| Q2 25 | $-29.3M | — | ||
| Q1 25 | $-17.8M | — | ||
| Q4 24 | $-11.0M | — | ||
| Q3 24 | $-11.1M | $-49.7M | ||
| Q2 24 | $-24.4M | $-33.9M | ||
| Q1 24 | $-32.5M | $-45.1M | ||
| Q4 23 | $-18.0M | — |
| Q3 25 | -12.1% | 68.4% | ||
| Q2 25 | -20.0% | — | ||
| Q1 25 | -12.5% | — | ||
| Q4 24 | -7.6% | — | ||
| Q3 24 | -7.7% | — | ||
| Q2 24 | -16.1% | — | ||
| Q1 24 | -21.4% | — | ||
| Q4 23 | -11.4% | — |
| Q3 25 | 1.7% | 0.0% | ||
| Q2 25 | 1.6% | — | ||
| Q1 25 | 3.2% | — | ||
| Q4 24 | 0.4% | — | ||
| Q3 24 | 5.5% | — | ||
| Q2 24 | 6.7% | — | ||
| Q1 24 | 2.7% | — | ||
| Q4 23 | 3.4% | — |
| Q3 25 | — | 1.19× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FAT
| Restaurant Sales | $96.6M | 69% |
| Royalty | $21.6M | 15% |
| Factory | $9.6M | 7% |
| Advertising | $9.1M | 7% |
| Franchisor | $1.5M | 1% |
| Other | $1.5M | 1% |
IDYA
Segment breakdown not available.
